Stephanie Hoops

Senior Market Analyst, Market Access Insights

State review boards take on drug prices amid Congressional inaction

How are states tackling high drug prices and increasing affordability? Clarivate market access expert Stephanie Hoops discusses the emergence of affordability review boards. Done waiting for Congress to take action on drug prices, states are increasingly enacting laws that create drug affordability review boards. As is done with utilities or insurance premiums, the boards allow states […]

Trump targets drug prices – 5 implications for pharma

On July 24, 2020, President Trump signed several executive orders directing the secretary of Health and Human Services (HHS) to take steps to lower drug prices. The directive includes the following measures: 1. International pricing index The most aggressive policy directive tasks the HHS secretary with linking the price of Medicare prescription drugs to an […]